IPO-trimethylation of Histone H3-Lysine9associated With P210 BCR-ABL Tyrosine Kinase of Chronic Myeloid Leukaemia

British Journal of Haematology - United Kingdom
doi 10.1111/j.1365-2141.2008.07134.x
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

Incidence and Outcome of BCR‐ABL Mutated Chronic Myeloid Leukemia Patients Who Failed to Tyrosine Kinase Inhibitors

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Genomic Mechanisms of P210 BCR-ABL Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Differential Genomics and Transcriptomics Between Tyrosine Kinase Inhibitor-Sensitive and -Resistant BCR-ABL-dependent Chronic Myeloid Leukemia

Oncotarget
Oncology
2018English

E19a2 BCR-ABL Fusion Transcript in Typical Chronic Myeloid Leukaemia: A Report of Two Cases

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Combined Inhibition of MDM2 and BCR-Abl Tyrosine Kinase Targets Chronic Myeloid Leukemia Stem/Progenitor Cells in a Murine Model

Haematologica
Hematology
2019English

Stochastic Modelling of Tyrosine Kinase Inhibitor Rotation Therapy in Chronic Myeloid Leukaemia

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

P210 and P190 BCR-ABL Fusion Transcripts Variants Frequencies Among Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Sudan

International Journal of Biomedical Research
2018English

Current Status of ABL Tyrosine Kinase Inhibitors Stop Studies for Chronic Myeloid Leukemia

Stem Cell Investigation
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy